Copyright
©The Author(s) 2015.
World J Diabetes. Mar 15, 2015; 6(2): 271-283
Published online Mar 15, 2015. doi: 10.4239/wjd.v6.i2.271
Published online Mar 15, 2015. doi: 10.4239/wjd.v6.i2.271
Ref. | Ethnicity | Population | Sample size, total (outcome) | Mean follow-up years | Main exposures | Outcome | Exposure level (mean or median) | Maximum effect (highest vs ref.) |
Cross-sectional study | ||||||||
Goodman-Gruen et al[39] | Mix1 | Postmenopausal women, aged 45-74 yr | 208 | - | Dietary isoflavones | Diabetes biomarkers | 4.4 mg/d genistein (mean) | Inverse with 2-h insulin (β = -0.2); not significant for FG and insulin |
Yang et al[38] | Chinese | Women aged 40-70 yr | 39385 (323) | - | Tofu and other soy products | Glycosuria | 9 g/d soy protein | Inverse association in postmenopausal women |
van der Schouw et al[42] | Caucasian | Men aged 47-83 yr | 468 | - | Dietary lignans and isoflavones | Diabetes biomarkers | Approximately 1 mg/d total phytoestrogens | Inverse association of lignans with fasting insulin and C-peptide; no significant association with isoflavones |
Pan et al[11] | Chinese | Men and women aged 50-70 yr | 2811 | - | Dietary soy protein | Hyperglycemia (FG ≥ 5.6 mmol/L) | 7.8 g/d soy protein | Increased odds in men, but not in women |
Shi et al[41] | Mix1 | Pregnant women aged 28 yr | 299 | - | Urinary isoflavones | Diabetes biomarkers | 502 mg/g creatinine | Inverse association with FG, insulin, and HOMA-IR |
Longitudinal study | ||||||||
Villegas et al[44] | Chinese | Women aged 40-70 yr | 64191 (896) | 4.6 | Soy protein, soybeans, soy products | T2D | 7.7 g/d soy protein | Inverse association with soybeans; inverse but not significant relation with soy protein or other products |
Nanri et al[46] | Japanese | Men and women aged 45-75 yr | 59791 (1114) | 5 | Soy products, daidzein, genistein | T2D | Approximately 73 g/d soy products, approximately 23 mg/d genistein, and 14.5 mg/d daidzein | No significant association |
Morimoto et al[47] | Mix2 | Men and women aged 45-75 yr | 75344 (8564) | 14 | Soy products | T2D | Approximately 14.5 g/d in Japanese, approximately 8 g/d in Hawaiians, and 0 g/d in Caucasians | A modest increased risk in men and women |
Mueller et al[45] | Chinese | Men and women aged 45-74 yr | 43176 (2252) | 5.7 | Isoflavones, unsweetened and sweetened soy products | T2D | Approximately 5.2 g/d for soy protein, 15.8 mg/d for soy isoflavones | Inverse association for soy isoflavones and unsweetened soy products, while increased risk for sweetened soybean drinks |
Zamora-Ros et al[48] | European whites | Men and women with mean age 52.4 yr | 11559 cases and 15258 subcohort, case-cohort design | Approximately 12 | Dietary isoflavones and lignans | T2D | 0.9 mg/d isoflavones, 1.4 mg/d lignans | No significant association for isoflavones and lignans |
Sun et al[49] | Caucasian | Women aged 65.6 yr from NHS and 45.4 from NHS II | 1107 cases and 1107 controls, nested case-control design | Approximately 6 | Urinary lignin metabolites (enterodiol and enterolactone) | T2D | 2.2 μmol/g creatinine for NHS women, and 1.9 μmol/g creatinine for NHS II women | Inverse association and odds ratio 0.64 (95%CI: 0.45-0.91) comparing extreme quartiles |
- Citation: Talaei M, Pan A. Role of phytoestrogens in prevention and management of type 2 diabetes. World J Diabetes 2015; 6(2): 271-283
- URL: https://www.wjgnet.com/1948-9358/full/v6/i2/271.htm
- DOI: https://dx.doi.org/10.4239/wjd.v6.i2.271